Overview

SweetMama is a new technological tool created to provide education for expecting mothers with type 2 diabetes. Investigators at Northwestern University are conducting a clinical trial on the effectiveness of SweetMama. The trial will consist of individual focus group and participant input and testing.

Study Information

The study will follow a text message curriculum of diabetes education to assess pregnant women with type 2 diabetes. Interviews will be conducted from focus groups of 10-20 low income, pregnant women on the tool’s effectiveness. The women will then be tested and followed by interviews and questionnaires.

Inclusion Criteria

• Females, ages 18 to 50 years old
• Currently diagnosed with gestational diabetes mellitus or type 2 diabetes mellitus
• Ability to speak English
• Gestational diabetes mellitus or type 2 diabetes mellitus
• Focus Groups: Confirmed pregnancy from 8 weeks to 12 weeks after delivery
• Individual testing: Confirmed pregnancy prior to 30 weeks
• Pilot trial: Confirmed pregnancy prior to 30 weeks
• Low-income economic status

Exclusion Criteria

• Unable to meet inclusion criteria

Locations

The study is being held at Northwestern Memorial Hospital in Chicago, Illinois, 60611. If you have any questions feel free to contact Lynn M Yee, MD, MPH, at 312-472-4685 or at lynn.yee@northwestern.edu. 

Sponsors/Collaborators

This clinical trial is sponsored by Northwestern University. The Principal Investigator is Lynn M Yee, MD, MPH, an Assistant Professor of Maternal and Fetal Medicine at Northwestern University.